Asthma Control-A "Patient Follow up Programme" Maintenance and Reliever Therapy in a Single Inhaler
Information source: AstraZeneca
Information obtained from ClinicalTrials.gov on February 12, 2009
Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Asthma
Phase: N/A
Status: Recruiting
Sponsored by: AstraZeneca Official(s) and/or principal investigator(s):
Dinh Ngoc SY, MD, Study Chair, Affiliation: TB and Lung Disease Hospital, Hanoi
Tran Van Ngoc, MD, PhD, Study Chair, Affiliation: Cho Ray Hospital
Nguyen Hong Duc, Study Chair, Affiliation: Pharm Ngoc Thach Hospital
Do Van Dung, MD, PhD, Study Chair, Affiliation: Ho Chi Minh City Univ of Medicine and Pharmacist
Overall contact:
AstraZeneca Vietnam Clinical Study, Information, Phone: +84-8278088, Email: ngocthieu.nguyen@astrazeneca.com
Summary
To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6
weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.
Clinical Details
Official title: A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)
Study design: Natural History, Cross-Sectional, Convenience Sample, Prospective Study
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- Asthma patients from both sexes, age 18 or older
- Have already been on Symbicort SMART treatment
- Willing to give written informed consents to participate in the program.
Exclusion Criteria:
- Patients who are not willing to give written informed consent
- Patients in emergency care for asthma at ICUs or COPD patients are excluded from the
program.
Locations and Contacts
AstraZeneca Vietnam Clinical Study, Information, Phone: +84-8278088, Email: ngocthieu.nguyen@astrazeneca.com
Research Site, Ho Chi Minh City, Vietnam; Recruiting
Research Site, Hanoi, Vietnam; Recruiting
Additional Information
Starting date: July 2007
Last updated: August 31, 2007
|
